Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Abroad (travel likely)RecruitingPHASE3

Conditions

Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Shicheng Su, M.D., Ph.D.) · lnl_trial@126.com · +86 13632394954
Contact: Study coordinator (Erwei Song, M.D., Ph.D.) · lnl_trial@126.com · +86 13719237746

Study leads

Shicheng Su
Principal Investigator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC

Breast Neoplasms

Abroad (travel likely)Recruiting

Suzhou, China

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Cervical Cancer · Gastric/Gastroesophageal Junction Adenocarcinoma · Microsatellite Stable Colorectal Cancer

IsraelRecruitingPHASE1, PHASE2

Clovis, United States · Los Angeles, United States

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Heart Failure · Anthracycline-induced Cardiac Toxicity · Endothelial Function (FMD)

Abroad (travel likely)RecruitingPHASE2

Ljubljana, Slovenia